Showing results (141-150 of 193) with videos related to
Sort By:
Pageof 20
AIDS (London, England)|August 11, 2007
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell countAndrew N Phillips, Brian Gazzard, Richard Gilson, et al.HIV Medicine|September 16, 2021
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in EnglandAlison E Brown, Sara E Croxford, Sophie Nash, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2009
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal, Amanda Mocroft, Jonathan A C Sterne, et al.Lancet (London, England)|July 6, 2004
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classesBruno Ledergerber, Jens D Lundgren, A Sarah Walker, et al.The Journal of Infectious Diseases|April 10, 2004
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipientsFrank M Mattes, Emma G Hainsworth, Anna-Maria Geretti, et al.Antiviral Therapy|June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimenAnna Schultze, Roger Paredes, Caroline Sabin, et al.The Journal of Antimicrobial Chemotherapy|February 26, 2013
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoringAlan Winston, Sophie Jose, Sara Gibbons, et al.BMJ (Clinical Research Ed.)|October 13, 2011
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) StudyMargaret May, Mark Gompels, Valerie Delpech, et al.AIDS (London, England)|March 15, 2005
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAndrew N Phillips, David Dunn, Caroline Sabin, et al.BMJ Open|May 11, 2023
CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and CanadaElisa Ruiz-Burga, Shema Tariq, Giota Touloumi, et al.Pageof 20